Greywolf Therapeutics
ActiveRegistered as Grey Wolf Therapeutics Limited
Data to 4 Nov 2026, 01:07
- Company number
- 10989365
- Sector
- Health and life sciences
- SIC group
- Life sciences and health
- Region
- South East (Abingdon)
- Incorporated
- 29 Sep 2017
- SIC code
- 72110
- Trading name
- Greywolf Therapeutics
- Website
- greywolftherapeutics.com Company number on the site, checked 16 Oct 2026
Greywolf Therapeutics has 2 priced rounds on record from share allotment filings at Companies House. The latest was allotted on 22 May 2024, raised £20.0m, and was filed on 3 Jun 2024. Data to 3 Nov 2026.
2
Priced rounds
Allotted Apr 2024 to May 2024
£34.2m
Cash raised in those rounds
Sum of sterling cash raised in each round, as filed
22 May 2024
Latest round allotted
Filed 3 Jun 2024
Jump to
Funding rounds
Priced equity rounds read from share allotment filings at Companies House, newest first.
| Allotted | First filed | Cash raised | Filing |
|---|---|---|---|
| 22 May 2024Latest | 3 Jun 2024 | £20.0m | Open filing |
| 5 Apr 2024 | 9 May 2024 | £14.3m | Open filing |
Companies with significant control
Companies with significant control over Greywolf Therapeutics, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.
| Holder | Notified | Ceased | Shares held |
|---|---|---|---|
| Biodiscovery 5 Fpci | 12 Feb 2019 | 12 Feb 2019 | 25 to 50% |
| Canaan XI L.P. | 12 Feb 2019 | 12 Feb 2019 | 25 to 50% |
From the PSC register.
Filings
The latest 6 capital filings other than share allotments (SH01), which are listed under Funding rounds. 63 share filings (SH01, SH02, SH03, SH06, SH08 and SH10) have been read for this company.
| Date | Filing | Document |
|---|---|---|
| 17 Aug 2026 | Purchase of own shares (SH03) | Open at Companies House |
| 29 Jul 2026 | Resolution | Open at Companies House |
| 6 Jul 2026 | Cancellation of shares (SH06) | Open at Companies House |
| 25 Jun 2026 | Cancellation of shares (SH06) | Open at Companies House |
| 23 Jun 2026 | Cancellation of shares (SH06) | Open at Companies House |
| 11 Mar 2026 | Resolution | Open at Companies House |
Documents open at Companies House. Bradshaw does not store or re-host them.
About this page
This page shows public register data for Greywolf Therapeutics. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.
Last updated 3 Nov 2026